Merits and Challenges of IPSC-derived Organoids for Clinical Applications

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2023 Jun 12

PMID 37305682

Authors

Ziran Xu

Jiaxu Yang

Xianyi Xin

Chengrun Liu

Lisha Li

Xianglin Mei

Meiying Li

Affiliations

Soon will be listed here.

Abstract

Induced pluripotent stem cells (iPSCs) have entered an unprecedented state of development since they were first generated. They have played a critical role in disease modeling, drug discovery, and cell replacement therapy, and have contributed to the evolution of disciplines such as cell biology, pathophysiology of diseases, and regenerative medicine. Organoids, the stem cell-derived 3D culture systems that mimic the structure and function of organs , have been widely used in developmental research, disease modeling, and drug screening. Recent advances in combining iPSCs with 3D organoids are facilitating further applications of iPSCs in disease research. Organoids derived from embryonic stem cells, iPSCs, and multi-tissue stem/progenitor cells can replicate the processes of developmental differentiation, homeostatic self-renewal, and regeneration due to tissue damage, offering the potential to unravel the regulatory mechanisms of development and regeneration, and elucidate the pathophysiological processes involved in disease mechanisms. Herein, we have summarized the latest research on the production scheme of organ-specific iPSC-derived organoids, the contribution of these organoids in the treatment of various organ-related diseases, in particular their contribution to COVID-19 treatment, and have discussed the unresolved challenges and shortcomings of these models.

Citing Articles

Induced pluripotent stem cell-related approaches to generate dopaminergic neurons for Parkinson's disease.

Yi L, Woon H, Saw G, Zeng L, Tan E, Zhou Z Neural Regen Res. 2024; 20(11):3193-3206.

PMID: 39665833 PMC: 11881713. DOI: 10.4103/NRR.NRR-D-24-00771.

A comprehensive review of electrophysiological techniques in amyotrophic lateral sclerosis research.

Ren K, Wang Q, Jiang D, Liu E, Alsmaan J, Jiang R Front Cell Neurosci. 2024; 18:1435619.

PMID: 39280794 PMC: 11393746. DOI: 10.3389/fncel.2024.1435619.

Challenges and Future Perspectives in Modeling Neurodegenerative Diseases Using Organ-on-a-Chip Technology.

Pramotton F, Spitz S, Kamm R Adv Sci (Weinh). 2024; 11(32):e2403892.

PMID: 38922799 PMC: 11348103. DOI: 10.1002/advs.202403892.

Induced Pluripotent Stem Cells and CRISPR-Cas9 Innovations for Treating Alpha-1 Antitrypsin Deficiency and Glycogen Storage Diseases.

Walsh C, Jin S Cells. 2024; 13(12.

PMID: 38920680 PMC: 11201389. DOI: 10.3390/cells13121052.

Prospects of induced pluripotent stem cells in treating advancing Alzheimer's disease: A review.

Park J, Rim Y, Sohn Y, Nam Y, Ju J Histol Histopathol. 2024; 40(2):157-170.

PMID: 38847077 DOI: 10.14670/HH-18-766.

References

Lee D, Su J, Kim H, Chang B, Papatsenko D, Zhao R . Modeling familial cancer with induced pluripotent stem cells. Cell. 2015; 161(2):240-54. PMC: 4397979. DOI: 10.1016/j.cell.2015.02.045. View

Wang W, Niu X, Stuart T, Jullian E, Mauck 3rd W, Kelly R . A single-cell transcriptional roadmap for cardiopharyngeal fate diversification. Nat Cell Biol. 2019; 21(6):674-686. PMC: 7491489. DOI: 10.1038/s41556-019-0336-z. View

Otani T, Marchetto M, Gage F, Simons B, Livesey F . 2D and 3D Stem Cell Models of Primate Cortical Development Identify Species-Specific Differences in Progenitor Behavior Contributing to Brain Size. Cell Stem Cell. 2016; 18(4):467-80. PMC: 4826446. DOI: 10.1016/j.stem.2016.03.003. View

Daley G, Hyun I, Apperley J, Barker R, Benvenisty N, Bredenoord A . Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines. Stem Cell Reports. 2016; 6(6):787-797. PMC: 4912385. DOI: 10.1016/j.stemcr.2016.05.001. View

Trujillo C, Gao R, Negraes P, Gu J, Buchanan J, Preissl S . Complex Oscillatory Waves Emerging from Cortical Organoids Model Early Human Brain Network Development. Cell Stem Cell. 2019; 25(4):558-569.e7. PMC: 6778040. DOI: 10.1016/j.stem.2019.08.002. View

Low J, Li P, Chew E, Zhou B, Suzuki K, Zhang T . Generation of Human PSC-Derived Kidney Organoids with Patterned Nephron Segments and a De Novo Vascular Network. Cell Stem Cell. 2019; 25(3):373-387.e9. PMC: 6731150. DOI: 10.1016/j.stem.2019.06.009. View

Kanton S, Boyle M, He Z, Santel M, Weigert A, Sanchis-Calleja F . Organoid single-cell genomic atlas uncovers human-specific features of brain development. Nature. 2019; 574(7778):418-422. DOI: 10.1038/s41586-019-1654-9. View

Youk J, Kim T, Evans K, Jeong Y, Hur Y, Hong S . Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2. Cell Stem Cell. 2020; 27(6):905-919.e10. PMC: 7577700. DOI: 10.1016/j.stem.2020.10.004. View

Hogberg H, Bressler J, Christian K, Harris G, Makri G, ODriscoll C . Toward a 3D model of human brain development for studying gene/environment interactions. Stem Cell Res Ther. 2014; 4 Suppl 1:S4. PMC: 4029162. DOI: 10.1186/scrt365. View

10.

Samuel R, Daheron L, Liao S, Vardam T, Kamoun W, Batista A . Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2013; 110(31):12774-9. PMC: 3732948. DOI: 10.1073/pnas.1310675110. View

11.

Kotini A, Chang C, Chow A, Yuan H, Ho T, Wang T . Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia. Cell Stem Cell. 2017; 20(3):315-328.e7. PMC: 5337161. DOI: 10.1016/j.stem.2017.01.009. View

12.

Morizane R, Lam A, Freedman B, Kishi S, Valerius M, Bonventre J . Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat Biotechnol. 2015; 33(11):1193-200. PMC: 4747858. DOI: 10.1038/nbt.3392. View

13.

Ho B, Pek N, Soh B . Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells. Int J Mol Sci. 2018; 19(4). PMC: 5979503. DOI: 10.3390/ijms19040936. View

14.

Azuma K, Yamanaka S . Recent policies that support clinical application of induced pluripotent stem cell-based regenerative therapies. Regen Ther. 2019; 4:36-47. PMC: 6581825. DOI: 10.1016/j.reth.2016.01.009. View

15.

Mseka T, Bamburg J, Cramer L . ADF/cofilin family proteins control formation of oriented actin-filament bundles in the cell body to trigger fibroblast polarization. J Cell Sci. 2007; 120(Pt 24):4332-44. DOI: 10.1242/jcs.017640. View

16.

Takebe T, Sekine K, Kimura M, Yoshizawa E, Ayano S, Koido M . Massive and Reproducible Production of Liver Buds Entirely from Human Pluripotent Stem Cells. Cell Rep. 2017; 21(10):2661-2670. DOI: 10.1016/j.celrep.2017.11.005. View

17.

Brustle O . Developmental neuroscience: Miniature human brains. Nature. 2013; 501(7467):319-20. DOI: 10.1038/nature12552. View

18.

Voges H, Mills R, Elliott D, Parton R, Porrello E, Hudson J . Development of a human cardiac organoid injury model reveals innate regenerative potential. Development. 2017; 144(6):1118-1127. DOI: 10.1242/dev.143966. View

19.

Ebert A, Yu J, Rose Jr F, Mattis V, Lorson C, Thomson J . Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature. 2008; 457(7227):277-80. PMC: 2659408. DOI: 10.1038/nature07677. View

20.

Glannon W . The Value and Disvalue of Consciousness. Camb Q Healthc Ethics. 2016; 25(4):600-12. DOI: 10.1017/S0963180116000335. View